Kenvue Inc. (KVUE) Stock Price: $18.80+0.39 (+2.12%)
At close: Jun 24, 2026, 4:00 PM ET
The closing share price for Kenvue Inc. (KVUE) stock was $18.80 for Wednesday, June 24, 2026, up 2.12% on the day.
Longer view (total return, dividends reinvested): past 12 months -7.2% · 3-year avg -7.1%/yr
KVUE Price Chart
KVUE Key Metrics
See All MetricsLAST CLOSE PRICE
$18.80
52-WEEK RANGE
$14.02 - $22.87
BETA
0.50
% FROM 52W HIGH
-17.80%
MARKET CAP
$36.10B
DIVIDEND YIELD
4.41%
PE RATIO
trailing TTM
22.12
PE RATIO (FWD)
next-FY estimate
14.95
P/B RATIO
3.41
DEBT / EQUITY
0.79
REVENUE TTM
$15.29B
NET INCOME TTM
$1.62B
NET PROFIT MARGIN TTM
10.61%
TTM TOTAL RETURN
-7.20%
3Y TOTAL RETURN
-7.11%
5Y TOTAL RETURN
N/A
KVUE Earnings Preview
Next Earnings Date
Aug 6, 2026
42 days away
EPS Estimate
0.32
Revenue Est.
$3.96B
Last Quarter Results
EPS
$0.32
vs Estimate
$0.26
Revenue
$3.91B
vs Estimate
$3.84B
KVUE Analyst Ratings
Consensus Rating
Based on 12 analysts
Average Price Target
$19.50
+3.7% upside
Low
$18.00
Current
$18.80
High
$23.00
KVUE Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | $0.32 | $0.32 | $0.32 | 2 |
| Q2 2027 | $0.33 | $0.33 | $0.33 | 2 |
| Q3 2027 | $0.31 | $0.32 | $0.32 | 2 |
| Q4 2027 | $0.28 | $0.28 | $0.29 | 2 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $1.12 | $1.26 | $1.38 | 9 |
| FY 2028 | $1.26 | $1.33 | $1.46 | 4 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | $3.97B | $3.99B | $4.01B | 3 |
| Q2 2027 | $4.05B | $4.07B | $4.09B | 3 |
| Q3 2027 | $3.95B | $3.98B | $4.00B | 3 |
| Q4 2027 | $3.94B | $3.97B | $3.99B | 3 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | $15.88B | $16.02B | $16.24B | 10 |
| FY 2028 | $16.55B | $16.56B | $16.56B | 8 |
Source: FMP Analyst Consensus Estimates. Forward P/E uses the next-fiscal-year consensus EPS estimate (the same value shown in the Key Metrics strip).
Related Stocks
Consumer DefensiveKVUE Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1KVUE | $36.10B | $18.80 | +2.12% | -7.20% | N/A | N/A | — |
| 2KR | $36.06B | $58.48 | +2.51% | -18.72% | +10.68% | +7.41% | vs KVUE |
| 3ADM | $36.19B | $75.08 | -1.00% | +46.40% | +7.00% | +9.56% | vs KVUE |
| 4KMB | $35.88B | $108.10 | +1.28% | -11.61% | -0.35% | +1.60% | vs KVUE |
| 5HSY | $37.13B | $183.04 | +2.10% | +9.59% | +3.74% | +9.04% | vs KVUE |
| 6SYY | $38.54B | $80.59 | +1.65% | +9.30% | +3.57% | +7.65% | vs KVUE |
KVUE Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt
About Kenvue Inc.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- CEO
- Kirk L. Perry